Liberia Successfully Introduces a Vaccine Against Cervical Cancer

Liberia Successfully Introduces a Vaccine Against Cervical Cancer

Liberia’s Ministry of Health, WHO and partners held a ceremony at the Ebola treatment facility in Monrovia to celebrate the recovery and discharge of a 2-year-old boy, the final patient in a latest flare-up in Liberia. His 5-year-old brother recovered a week earlier.

Liberia’s and Guinea’s last known Ebola patients in a latest flare-up of the disease that hit both countries have now been discharged. All remaining contacts of confirmed cases that were placed under a 3-week period of medical monitoring have been cleared.

Liberia’s Ministry of Health, WHO and partners involved in the response held a ceremony at the Ebola treatment facility in Monrovia to celebrate the recovery and discharge of a 2-year-old boy, the final patient in the flare-up in Liberia. His 5-year-old brother recovered a week earlier. On 29 April, the country also began a 42-day period of increased surveillance – amounting to two 21-day incubation cycles of the virus. 

Guinea’s final Ebola patient, a 70-year-old man, tested negative for the virus a second time on 19 April and returned to his village in the southern prefecture of Macenta to a warm welcome. Guinea began its 42-day countdown on that day, and will be able to declare the flare-up over on 31 May if there are no additional cases. 

Click image to enlarge